Formulation and Optimization of Immediate Release Tablet of Sapropterin Dihydrochloride by Dry Granulation Process
Abstract
The research aims to develop and evaluate an immediate-release dosage form of sapropterin dihydrochloride to improve efficacy, stability, and patient acceptance in treating hyperphenylalaninemia (HPA), ensuring rapid therapeutic action upon administration. Formulation development began with a pre-formulation study to evaluate drug-excipient compatibility, solubility, and compressibility, followed by feasibility trials to create a prototype formulation. Dissolution tests and optimization methods, including DoE and OFAT, were employed to refine the formulation based on critical quality attributes. Process optimization involved identifying and fine-tuning critical parameters through sequential unit operations and risk assessments, ensuring uniformity and quality during scale-up for commercial production. The prototype formulation development for a tablet product based on the reference product Kuvan involved strategic excipient selection to meet critical quality attributes (CQA) and mitigate concerns like mottling. The formulation deviates from the reference by using LH 21 as a binder, colloidal silicon dioxide as a glidant, and omitting anhydrous dibasic calcium phosphate, with Mannitol SD (Pearlitol 200) chosen for its flowability and compressibility. The feasibility trial aimed at achieving pharmaceutical equivalence to Kuvan tablets, focusing on bioequivalence, stability, and API distribution, and involved top spray fluid bed granulation with roller compaction and blending identified as high-risk steps. Optimization of tablet formulation considered drug substance particle size, blend ratios, and excipient selection, with adjustments in intra and extra-granular ratios significantly impacting tablet characteristics.
Keywords: Immediate Release, Sapropterin Dihydrochloride, Dry Granulation Process
Keywords:
Immediate Release, Sapropterin Dihydrochloride, Dry Granulation ProcessDOI
https://doi.org/10.22270/jddt.v14i6.6583References
Angela T. S. Wyse, Tiago M. dos Santos, Bianca Seminotti & Guilhian Leipnitz, Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation, Molecular Neurobiology 2021;58:2897–2909. https://doi.org/10.1007/s12035-021-02304-1
PMid:33550493
Nyol S, Gupta MM, Immediate Drug Release Dosage Form: A Review, Journal of Drug Delivery & Therapeutics; 2013;3(2):155-161. https://doi.org/10.22270/jddt.v3i2.457
Rishikesh, Bhuyian MA, Dewan I, Ghosh DR, Islam I, Immediate Release Drug Delivery System (Tablets): An Overview, International Research Journal of Pharmaceutical and Applied Sciences, 2012;2(5):88-94.
Devi R, Kumar S, Immediate Release Dosage Forms: Thrust Areas and Challenges, International Journal of Current Advanced Research, 2018;7(5E):12550-12555.
Bing-Qiang Lu, Tom Willhammar, Ben-Ben Sun, Niklas Hedin, Julian D. Gale & Denis Gebauer, Introducing the crystalline phase of dicalcium phosphate monohydrate Nature Communications, 2020;11:1546, https://doi.org/10.1038/s41467-020-15333-6
PMid:32210234 PMCid:PMC7093545
Bley O, Siepmann J, Bodmeier R, Protection of moisture-sensitive drugs with aqueous polymer coatings: Importance of coating and curing conditions, International Journal of Pharmaceutics, 2009;378:59–65. https://doi.org/10.1016/j.ijpharm.2009.05.036
PMid:19477253
Published



How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).